Sep

18

2021

What is the overall risk of progression to multiple myeloma in a patient with monoclonal gammopathy of undetermined significance (MGUS)?

By William Aird

A

What is the overall risk of progression to multiple myeloma in a patient with monoclonal gammopathy of undetermined significance (MGUS)?

About 1% per year

Posted on September 18, 2021

Stay Updated

If you are interested in getting the latest articles from The Blood Project, enter your name and email

  • This field is for validation purposes and should be left unchanged.